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ABSTRACT We investigated the 
biochemical and biophysical properties of one 
of the four alternative exon-encoded regions 
within the Drosophila myosin catalytic domain. 
This region is encoded by alternative exons 3a 
and 3b and includes part of the N-terminal β–
barrel. Chimeric myosin constructs (IFI-3a and 
EMB-3b) were generated by exchanging the 
exon 3-encoded areas between native slow 
embryonic body wall (EMB) and fast indirect 
flight muscle myosin isoforms (IFI). We found 
that this exchange alters the kinetic properties 
of the myosin S1 head. The ADP release rate (k-
D) in the absence of actin is completely reversed 
for each chimera compared to the native 
isoforms. Steady-state data also suggest a 
reciprocal shift, with basal and actin-activated 
ATPase activity of IFI-3a showing reduced 
values compared to wild-type IFI, whereas for 
EMB-3b these values are increased compared to 
wild-type EMB. In the presence of actin, ADP 
affinity (KAD) is unchanged for IFI-3a, 
compared to IFI, but ADP-affinity for EMB-3b 
is increased, compared to EMB, and shifted 
towards IFI values. ATP-induced dissociation 
of acto-S1 (K1k+2) is reduced for both exon 3 
chimeras. Homology modeling, combined with 
a recently reported crystal structure for 
Drosophila EMB, indicate that the exon 3 
encoded region in the myosin head is part of the 
communication pathway between the 
nucleotide binding pocket (purine-binding 
loop) and the essential light chain, emphasizing 
an important role for this variable N-terminal 
domain in regulating acto-myosin cross-bridge 
kinetics, in particular with respect to the force-




Muscle myosin isoforms display a large 
variety in kinetic properties and force 
production, despite their sequences being 
highly conserved. The various isoforms of 
Drosophila melanogaster muscle myosin heavy 
chain (MHC) are encoded by a single gene 
(Mhc) and expressed using alternative splicing 
(1). The first four of the six alternative exon sets 
(exons 3, 7, 9 and 11) encode regions located in 
the myosin head domain (2) and the use of 
alternative domains in the myosin head allows 
for fine-tuning of myosin properties (see Figure 
1A). Two native myosin isoforms that differ in 
all four alternative regions in the head domain 
display very different kinetic and mechanical 
properties. The EMB (embryonic) myosin 
isoform is found in the embryonic body wall 
muscle, which is used for slow locomotion of 
the larvae, whereas the IFI (indirect flight 
muscle isoform) myosin is present in the muscle 
that can generate very high wing beat 
frequencies and enables flight. Transgenic 
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expression of EMB in the indirect flight muscle 
resulted in loss of flight ability (3) and 
subsequent studies using isolated muscle fibers 
and/or myosin proteins confirmed the striking 
differences in kinetic and mechanical properties 
between IFI and EMB myosin isoforms (4–6). 
Exchange of the variable regions between IFI 
and EMB has been used as a strategy to estimate 
the effect of each alternative domain on muscle 
myosin kinetics and mechanics. Here we focus 
on the variable region near the N-terminus of 
MHC, encoded by exon 3. Two alternative 
regions, encoded by exons 3a and 3b, are 
expressed in Drosophila myosin and their 
sequences are shown in Figure 1B. EMB 
contains the region encoded by exon 3a, while 
the exon 3b encoded sequence is normally 
expressed within IFI. Previous work found that 
exchange of the exon 3 regions between IFI and 
EMB significantly changes the steady-state 
kinetic properties of both Drosophila muscle 
myosin isoforms. Inserting the exon 3a area into 
IFI resulted in significantly reduced ATPase 
rates and Vmax for IFI-3a (compared to IFI), 
whereas inserting the exon 3b region into EMB 
had surprisingly little effect on ATPase and Vmax 
of EMB-3b (compared to EMB) (7). The same 
study showed that in vitro actin sliding velocity 
was increased for EMB-3b, although not 
restored to IFI levels, and unaltered for IFI-3a, 
compared to wild type.  
Exchange of the exon 3 area also affects 
the mechanical properties of the indirect flight 
muscle. Flight ability of IFI-3a Drosophila is 
slightly decreased, compared to wild-type, 
whereas introduction of the exon 3b region in 
an embryonic background does not restore 
flight ability for EMB-3b Drosophila (7). A 
follow-up study found that IFI-3a Drosophila 
showed a reduction in both maximum power 
generation (Pmax) and optimal frequency for 
power production (fmax), whereas for EMB-3b 
Drosophila an increase in both Pmax and fmax was 
found (8). Based on these results it was 
suggested that the exon 3 region can influence 
at least two steps of the cross-bridge cycle 
independently, thereby fine-tuning myosin 
muscle kinetics for optimal force generation. To 
understand the biochemical kinetics of various 
steps in the cross-bridge cycle that are 
influenced by the exon 3 domain, we have now 
performed steady-state and transient kinetics 
measurements using the exon 3 chimeric 
myosin S1 isoforms (IFI-3a and EMB-3b). Our 
data show that exchange of this variable N-
terminal area significantly alters the kinetic 
properties of the myosin S1 head. The catalytic 
activity kcat of the myosin S1 samples generated 
from all full-length molecules (IFI, EMB, 
EMB-3b, and IFI-3a) followed the trend of 
activities so far observed for the full-length 
molecules. Interestingly, the ADP release rate 
(k-D) in the absence of actin is completely 
reversed for both chimeras, compared to their 
wild-type backbones. In the presence of actin, 
the ADP affinity (KAD) is unchanged for IFI-3a, 
whereas ADP-affinity for EMB-3b is increased 
and shifted towards IFI values. ATP-induced 
dissociation of acto-S1 (K1k+2) is reduced for 
both exon 3 chimeras. Detailed analysis of a 
recently published crystal structure for EMB (9) 
combined with homology modeling indicate 
that the exon 3 encoded area is part of the 
communication pathway between the 
nucleotide binding pocket (purine-binding 
loop) and the essential light chain, emphasizing 
an important role for exon 3 in regulating acto-
myosin cross-bridge kinetics, in particular with 




ATP-induced dissociation of acto-S1 (K1k+2) is 
reduced for both exon 3 mutants  
The ATP-induced dissociation of the 
acto-S1 complex was measured as described 
previously (10) using the flash photolysis 
method. Plotting the observed rate constant kobs 
versus ATP concentration allows the apparent 
second-order rate constant K1k+2 to be 
determined from the slope of the graph. 
Example traces of the measured light scattering 
data are shown in Figure 2A for EMB-3b after 
ATP release. The analyzed data are depicted in 
Figure 2B for the two exon 3 chimeras, together 
with IFI and EMB wild type (see also Table 1). 
The measured K1k+2 value of EMB-3b 
(0.71±0.12 μM-1s-1) is significantly lower 
compared to EMB (p<0.007, Table 1) but not 
significantly different from the value previously 
recorded for IFI (0.75±0.08 μM-1s-1). For IFI-3a, 
a significantly lower K1k+2 value (0.66±0.08 
μM-1s-1) compared to IFI was recorded using an 
unpaired t test (p<0.04, Table 1), although this 
difference did not reach statistical significance 
using a more stringent one-way Welch’s 
ANOVA that compared all four constructs. 
Thus, introduction of the IFI version of the exon 
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3 region into EMB shifted the ATP-induced 
dissociation of EMB-3b towards IFI values, 
whereas the presence of the EMB version of the 
exon 3 region did not shift IFI-3a towards wild-
type EMB levels. 
 
ADP-affinity (KAD) is unchanged for IFI-3a 
but increased for EMB-3b compared to wild-
type 
The ADP-affinity for S1 in the presence 
of actin, described by the equilibrium 
dissociation constant KAD, was determined 
according to established methods (5). ATP-
induced dissociation of acto-S1 was measured 
in the presence of increasing amounts of ADP. 
Figure 2C shows example traces of the light 
scattering data for EMB-3b, recorded with 
increasing ADP concentration. The amplitude 
of the signal drops as the ADP concentration 
increases. From the light scattering signals, kobs 
can be obtained by fitting to a single exponential 
and plotting kobs versus ADP-concentration, 
which allows KAD to be estimated. The data 
show that the measured value for the embryonic 
chimera EMB-3b (KAD = 496 ± 79 μM) is 
significantly lower, as assessed by t test, 
compared to the wild-type EMB value (KAD = 
587 ± 48 μM), suggesting a tighter ADP-
binding affinity for EMB-3b (Figure 2C), 
although this did not reach statistical 
significance using Welch’s one-way ANOVA. 
The measured value of KAD for IFI-3a (KAD = 
409±18 μM) is not significantly different from 
the wild-type IFI value (see Table 1). 
 
The ADP-release rate of S1 (k-D) is reversed 
for both IFI-3a and EMB-3b chimeras 
To estimate the rate constant of ADP 
dissociation from S1 in the absence of actin, the 
change in fluorescence of a coumarin-labelled 
ADP analog (eda-deac ADP, (11) was measured 
upon displacement of eda-deac ADP (cmADP) 
by ATP-binding to S1 (12). A single laser flash 
released 15-20 µM ATP from cATP (100 µM) 
and the fluorescence change resulting from 
cmADP release was recorded (Figure 3). The 
fluorescence signal could be fitted to a single 
exponential, which gives the ADP-release rate 
(k-D). The small increase in fluorescence at the 
start of the transient is an artefact resulting from 
the laser flash which is difficult to eliminate 
entirely when working with low fluorescence 
signals as used here.  Note the direction of the 
change is the same in both transients. 
The two exon 3 chimeras, IFI-3a and 
EMB-3b, show an almost complete reversal of 
their k-D values compared to their wild-type 
counterparts (Table 1). Insertion of the 
embryonic exon 3a area into IFI results in an 
ADP release rate typically found in wild-type 
EMB (k-D = 2.1 ± 0.41 s-1), whereas the 
introduction of the fast IFI exon 3b region into 
EMB increases the ADP-release rate of EMB-
3b to wild-type IFI levels (k-D = 7.0 ± 1.3 s-1). 
Reversal of k-D rates after exon exchange was 
previously found for one of the other variable 
domains, the relay loop encoded by exon 9, as 
introduction of the exon 9a domain into IFI 
reduced the ADP-release rate to embryonic 
levels, whereas the substitution of the exon 9b 
region into EMB increased the ADP-release 
rate to IFI-levels (10).  
The directionality of the observed 
fluorescence traces is variable and can even be 
reversed as seen here for EMB-3b. The 
fluorescence trace of IFI-3a shows a signal 
decrease after release of cmADP, similar to 
what was seen previously for IFI and EMB (5). 
However, EMB-3b fluorescence increases upon 
cmADP release and this reversal of the 
fluorescence signal has been observed in other 
studies. We previously reported a similar 
reversal of fluorescence change for a series of 
probes and myosin isoforms (12) and also for 
other chimeric Drosophila myosin isoforms 
after exchange of exon 7 (13) and exchange of 
exon 9 (10). We currently have no explanation 
of why this occurs, except that this must reflect 
a change in the environment of the fluorescent 
probe, that will require analysis of a high-
resolution structure to resolve. 
 
Catalytic activity is reduced for IFI-3a and 
increased for EMB-3b 
Basal and actin-activated ATPase 
activity of wild-type IFI S1 and the two exon 3 
mutants were measured (see Figure 4 and Table 
2). IFI-3a S1 showed a significant reduction in 
basal Ca-ATPase (4.92±1.05 s-1) compared to 
wild-type IFI S1 (9.79±1.39 s-1), whereas Ca-
ATPase activity of EMB-3b S1 (5.16±2.01s-1) 
is significantly increased compared to values 
for wild-type EMB (1.83±0.08 s-1) (Figure 4A 
and Table 2). The same trends were seen for 
basal Mg-ATPase activity, as well as actin-
activated ATPase values (Vmax), although 
differences did not reach statistical significance 
(Table 2 and Figure 4B/C). While previous Ca-
ATPase, Mg-ATPase and Vmax measurements 
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for full-length myosin (7) showed significantly 
reduced values for IFI-3a compared to IFI wild-
type, the full-length protein showed an increase 
only in Ca-ATPase levels for EMB-3b 
compared to EMB.  
Using flash photolysis, the turnover 
number (kcat) was measured at a fixed actin 
concentration for S1 of both exon 3 exchange 
mutants and compared with IFI wild type 
(Figure 4D). The time taken to hydrolyze all 
released ATP (tcat) was estimated from the time 
at which the dissociation reaction was 50% 
complete (tdiss) to the time for 50% recovery of 
light scattering (tass). This time period (tcat) is 
linearly dependent upon the amount of released 
ATP (see Figure 4D). The steady-state rate of 
ATP hydrolysis is the inverse of the slope 
(steady-state rate = [ATP]/tcat), allowing the 
catalytic activity (kcat) to be determined. For IFI 
a steady-state rate of 0.104 (μM s-1) was found, 
resulting in a kcat of 0.18 s-1. This value is 
essentially the same as the kcat value reported 
previously for IFI S1 using the same 
experimental setup (kcat = 0.17±0.006 s-1) (10). 
The catalytic activity of EMB-3b (kcat = 
0.021±0.009s-1) is nearly identical to the value 
measured previously for EMB (0.028 s-1), 
whereas the kcat value for IFI-3a (0.057±0.003 s-
1) shows a decrease compared to IFI (10) (see 
Table 1). Previously reported Vmax values for 
full length myosin constructs showed similar 
behavior (7), with unchanged Vmax values for 
EMB-3b compared to EMB, and a 2.36-fold 
decrease in Vmax for IFI-3a compared to IFI.  
 
Homology models and general description of 
the exon 3 encoded area  
Sequence alignment of various myosin 
isoforms show that the exon 3 area is highly 
variable, with only five residues that are fully 
conserved: Asp90, Asn105, Arg109, Ile115 and 
Tyr116 (Figure S1). The recently published 
crystal structure of embryonic Drosophila 
myosin in the rigor-like conformation (PDB 
5W1A) shows that the exon 3 region (residues 
69-116) starts with two β-strands (β4:69-73 and 
β5:77-79), which form part of the SH3-like 
domain found in many other myosins (Figure 
5A). The β4 and β5 strands are followed by two 
short helices (HA: 83-85 and HB: 91-93) and a 
longer helix C (residues 98-111). The C-
terminal residues of the exon 3 area are at the 
start of the next β-strand (S1B, Figure 5B) 
which forms the first β-strand of the central 
seven-stranded β-sheet in the myosin head.  
Conserved residue Asp90 is located 
between exon 3 helix A and helix B, residues 
Asn105 and Arg109 are located on the same side 
of helix C and Ile115 and Tyr116 are part of the 
first β-strand of the central 7-stranded β-sheet, a 
conserved feature of all myosins. The EMB 
crystal structure shows that Asp90 forms a 
strong salt-bridge with Arg148 and that the latter 
also forms a hydrogen-bond with Gly120, located 
between the first two β-strands of the central 7-
stranded β-sheet (Figure 5B). Conserved 
residue Asn105 forms hydrogen bonds with the 
backbone oxygen of three residues close to 
Asp90 (Lys87, Ile/Ala88 and Met91), whereas 
conserved residue Arg109 contacts Tyr116. 
The available crystal structure of 
embryonic Drosophila myosin in the rigor-like 
conformation (PDB 5W1A) was used as a 
template to generate a homology model for IFI 
myosin. Overlay of the IFI model and the EMB 
crystal structure showed that the backbone 
topology for both is very similar (rmsd of 1.59 
Ả). Inspecting the homology models using 
scallop myosin templates that represent 
conformations at different steps of the 
mechanochemical cycle shows that some of 
these conserved interactions are maintained 
throughout the cycle, whereas others are lost 
(see Discussion for details).  
 
Exon 3 interacts with the nucleotide binding 
site  
The kinetic data show that exchange of 
the exon 3 area alters the nucleotide binding 
properties of Drosophila myosins. A large body 
of research has established that nucleotide 
binding and processing in the active site of 
myosin involves four highly conserved loops: 
P-loop (GESGAGKT), switch 1 (AKTxxN(N 
D)NSSR), switch 2 (DIxGFE) and the purine 
binding loop (NPxxxxxxY) (14). The exon 3 
region (residues 69-116) could potentially alter 
nucleotide binding properties by interacting 
with any of these highly conserved loops. 
Inspection of the EMB crystal structure (Figure 
6A) shows that the purine binding loop 
(residues 127-135) interacts with the exon 3 
region; for example, exon 3 residue Tyr110 forms 
a hydrogen bond with purine binding loop 
residue Asn127 (Figure 6B). Asn127 also has a 
hydrogen bond with the backbone carbonyl of 
P-loop residue Gly182. These contacts suggest a 
role for the exon 3 region of the myosin head in 
regulating nucleotide binding and release via 
interaction with the purine binding loop. 
Myosin alternative N-terminal domains influence kinetics 
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Homology models derived from scallop 
myosin structures at various states of the cross-
bridge cycle were generated for both IFI and 
EMB and used for further analysis, since the 
EMB crystal structure is only available for a 
rigor-like configuration that has no nucleotide 
bound. The homology models confirm the 
interaction between the purine-binding loop and 
the exon 3 area, and suggest this interaction 
depends on the myosin state involved (see 
Figure S2 for a detailed description of these 
interactions for different myosin 
conformations). However, the interactions 
between the purine binding loop and the exon 3 
area are very similar for IFI and EMB (see 
Figure S2/S3 for details).  
The EMB crystal structure shows that 
the exon 3 region has no direct contacts with 
any of the other variable domains in the myosin 
head. However, the SH1-SH2 helix is wedged 
between the exon 3 and exon 9 (relay loop) 
regions and makes contacts with both variable 
domains. Since Drosophila EMB and IFI share 
the same SH1-SH2 sequence, the two variable 
regions could potentially interact differently 
with this element, thereby altering the myosin 
properties. However, detailed analysis showed 
that contacts between exon 3 residues and the 
highly conserved SH1-SH2 region in the 
myosin head were also found to be very similar 
for both chimeras (see Figure S4 for details). In 
summary, the conserved interaction of the exon 
3 region with both the nucleotide binding loop 
and the SH1-SH2 area suggest that alternative 
versions of exon 3 differentially affect myosin 
properties via another mechanism.  
 
Exon 3 interaction with the myosin essential 
light chain  
Part of the exon 3 area is embedded in 
the SH3 element, a β-barrel found at the N-
terminus of the MHC. In vertebrates this SH3 
element is thought to interact with the extended 
N-terminus of the myosin essential light chain 
(ELC) in the presence of actin, thereby 
modulating myosin ATPase kinetics (15). The 
EMB crystal structure does not show any direct 
contacts between the exon 3 region and the 
ELC, as the ELC of Drosophila lacks this N-
terminal extension (16). However, two ELC 
residues (Glu104 and His107) form salt-bridge/H-
bond contacts with two MHC residues located 
outside the SH3 domain (Arg25 and Ser29). The 
latter two are part of a small helix near the N-
terminus (helix NT), which is wedged in 
between the ELC and the SH3-exon 3 area 
(Figure 6A, C). Another residue located on this 
small helix (Asp27) forms a strong salt-bridge 
with exon 3 residue Lys87 (Figure 6C). Lys87 is 
part of a network of highly conserved 
interactions in the exon 3 area, as it makes 
contacts with conserved residues Arg109 and 
Asn105 (see Fig 5B). Lys87 (backbone oxygen) 
also interacts with the sidechain of helix NT 
residue Arg24 (Figure 6C). Therefore, the exon 
3 region is likely to be part of a communication 
pathway between the essential light chain and 
the purine binding loop, which also involves 
helix NT.  
Homology models for IFI show a 
similar picture when using the EMB crystal 
structure 5W1A as a template, with no direct 
ELC-exon 3 region contacts, but indirect 
contacts via helix NT (Figure 7A). Homology 
models representing other states in the cross-
bridge cycle indicate that for IFI, helix NT 
maintains contacts with the exon 3 region 
throughout the cycle, whereas for EMB these 
contacts are lost. For instance, the pre-power 
stroke state of IFI (using 1QVI as template) 
shows interactions between exon 3 residue 
Asn112 and helix NT residue Arg24 (Figure 7B). 
Exon 3 residue 112 is a variable residue, Ala112 
for EMB, and therefore the pre-power stroke 
state of EMB lacks this exon 3 contact with 
helix NT. The post-power stroke state of IFI 
(using 1KK8 as template) maintains the Asn112-
Arg24 contact and has additional interactions 
between the sidechain of Arg25 (helix NT) and 
the backbone oxygen of exon 3 residues Pro83 
and Lys84 (Figure 7C). For EMB the post-power 
stroke state again does not show any contacts 
between exon 3 and helix NT, indicating the 
interaction between the exon 3 region and helix 
NT is fundamentally different between the IFI 




The use of alternative domains in the 
myosin head is thought to play a role in fine-
tuning the kinetic and mechanical properties of 
myosin isoforms (2), but the exact mechanisms 
whereby alternative structures affect these 
properties are not well understood. Herein we 
investigate the structure-function relationship 
of the area encoded by exon 3, a variable 
domain that forms part of the SH3-fold found 
near the N-terminus of the myosin head. Our 
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results show that exchange of the exon 3 region 
between the indirect flight isoform (IFI) and the 
embryonic isoform (EMB) alters various kinetic 
properties of the generated myosin S1 chimeras 
(IFI-3a and EMB-3b). The most profound effect 
is on the ADP-release rates in the absence of 
actin, as the k-D values for the chimeras are 
completely reversed, compared to their wild-
type counterparts. In the presence of actin, the 
ADP affinity for IFI-3a is not affected 
compared to wild-type IFI. However, the ADP 
affinity of EMB-3b is significantly tighter, 
compared to wild-type EMB and shifts towards 
IFI values. ATP-induced dissociation is also 
affected after exchange of the exon 3 area 
between IFI and EMB, although the effect is 
less dramatic compared to ADP-release. 
Introduction of exon 3b into EMB shifted the 
ATP-induced dissociation towards IFI values, 
however, the insertion of the exon 3a region into 
an IFI background did not shift the ATP-
induced dissociation towards wild-type EMB 
levels. The steady-state kinetic parameters 
measured for the IFI, EMB, and exon 3 chimeric 
S1 isoforms show a similar pattern for kcat, with 
values of IFI-3a shifting towards the EMB 
donor isoform, but values for EMB-3b being 
very similar to EMB. While this pattern holds 
for IFI vs. IFI-3a values for Vmax and basal Ca- 
and Mg-ATPase, increases in these parameters 
were seen for EMB-3b relative to EMB.   
 
Correlation between K1k+2 or KAD and motility 
It is generally accepted that ADP 
release is rate-limiting for slow sarcomere 
myosin isoforms (17). In contrast, for faster 
myosins, ATP-induced dissociation can be rate-
limiting, depending on the particular conditions 
used (18) (19). Plotting the measured ADP 
affinity (KAD) for EMB, EMB-3b, IFI and IFI-
3a against previously reported in vitro motility 
values, with and without the actin-binding 
protein tropomyosin (Tpm) (7), shows a 
decrease in velocity with increasing KAD values 
(lower ADP affinity) (see Figure S5 and Table 
3). This implies that ADP release is not rate-
limiting for these Drosophila myosin isoforms, 
as the actin sliding velocity is higher for 
isoforms with higher ADP affinity. This agrees 
with previous biochemical studies that reported 
ADP affinity measured in solution did not 
correlate with actin sliding velocity of other 
Drosophila myosin isoforms (5, 10, 13). 
Mechanical studies on isolated Drosophila 
muscle fibers also found no correlation between 
ADP affinity and frequency of maximum work 
production (4, 8, 20, 21). Plotting in vitro 
motility versus ATP-induced dissociation 
(K1k+2) for IFI, EMB and the two exon 3 
chimeras, shows reduced motility with 
increasing K1k+2 values, although the 
correlation is not particularly strong (R2 = 0.86, 
Figure S5).  
 
ADP release (k-AD) is faster than ATP-induced 
dissociation of AM (kdiss) 
In order to estimate if either ADP 
release or ATP-induced dissociation could be 
rate limiting for these Drosophila myosins, the 
theoretical rate-limiting step kmin was calculated 
using the equation kmin = V/d, assuming a 
working stroke (d) of 5 nm (18) and using the 
published motility data for velocity in the 
presence (V*) and absence (V) of tropomyosin 
(Tm) (7). The calculated values for the rate-
limiting step kmin are listed in Table 3, together 
with the motility data and estimated values for 
ADP release (k-AD) and ATP-induced 
dissociation (kdiss). The values associated with 
ATP-induced dissociation (kdiss,2) are within 
2600-3600 s-1, whereas values estimated for 
ADP release (k-AD) are within 4000-5900 s-1. 
Thus, both ATP-induced dissociation and ADP 
release are significantly faster than the rate 
limiting step kmin (800-1200 s-1). Therefore, it 
seems unlikely that either ADP-release or ATP-
induced dissociation is rate-limiting under these 
conditions.  
At lower ATP concentrations, one 
predicts that kdiss could be limiting the velocity 
for these myosins, in particular for IFI, which 
has an unusual low affinity for ATP, compared 
to EMB (20). At 1 mM ATP concentration, 
kdiss,1 is around 1300-1800 s-1, close to the values 
calculated for kmin,5
*, indicating that at such low 
ATP concentrations kdiss can indeed be rate-
limiting for these myosins. At saturating ATP 
levels, another step in the cross-bridge cycle 
could become rate-limiting, for instance 
phosphate release (IFI) or an isomerization step 
before ADP release (EMB) as proposed by 
Swank et al. (20). However, EPR studies of 
Drosophila myosins, investigating the 
isomerization step between the open to closed 
conformation of the nucleotide binding pocket, 
found that the pocket is predominantly closed 
for both IFI and EMB with ADP bound. 
Therefore, this isomerization step is unlikely to 
control velocity for these fast myosin isoforms 
(22). Overall, our calculations suggest that 
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ADP-release is too fast to be rate-limiting, but 
ATP-induced dissociation could be rate-
limiting at lower [ATP]. 
 
Biological implications 
Homology modeling, combined with 
the crystal structure for Drosophila EMB, 
indicate that the exon 3 encoded region in the 
myosin head is part of a communication 
pathway between the nucleotide binding pocket 
(purine-binding loop) and the essential light 
chain via helix NT, emphasizing an important 
role for this variable N-terminal domain in 
regulating acto-myosin cross-bridge kinetics. 
IFI maintains the interaction between helix NT 
and exon 3 during the cross-bridge cycle for 
different conformational states, whereas for 
EMB these interactions are lost. The presence 
of helix NT-exon 3 contacts throughout the 
cross-bridge cycle allows the IFI isoform to 
rapidly communicate any conformational 
change from the nucleotide binding site towards 
the ELC and vice versa, whereas for the EMB 
isoform this process is likely to be slower, due 
to the loss of exon 3 – helix NT contacts.  
The presence of additional stabilizing 
interactions between the exon 3 region and helix 
NT for IFI throughout the cross-bridge cycle 
might be expected to stabilize the structure and 
make transitions between states more difficult 
thus reducing the reaction rates of it chemo- 
mechanical cycle compared to EMB, which is 
opposite to experimental data. In contrast to 
these expectations, the increased stability may 
restrict the number of conformational states the 
myosin head can adopt and actually improve its 
function. In this regard, a recent paper by 
Schmid and Hugel (23) explores this concept 
and introduces the idea of ‘conformational 
confinement of proteins’, in which the authors 
argue that restricting conformational states 
enhances the function of a protein "by limiting 
the non-productive degrees of freedom". For 
myosin IFI, the presence of helix NT-exon 3 
contacts throughout the cross-bridge cycle may 
therefore ensure that the conformational states 
of myosin are confined to those that enhance its 
function. 
If the exon 3 region plays an important 
role in the communication pathway between the 
essential light chain and the purine binding 
loop, via helix NT, any mutations along this 
route are expected to have a serious effect on the 
biological function of myosin. An extensive 
literature search (24) revealed that various 
cardiomyopathy mutations have been reported 
along this pathway, involving the exon 3 region, 
helix NT and the essential light chain. 
Mutations have been reported for exon 3 
residues Pro81, Ala100, and Tyr115 (the equivalent 
exon 3 encoded residues in Drosophila are 
Pro82, Ser101/Cys101 and Tyr116). Tyr115 can 
interact with the purine binding loop (Tyr116 in 
Figure S2 B/C) and therefore a mutation of 
Tyr115 is expected to alter this interaction and 
affect the nucleotide binding properties of 
myosin. The helix NT equivalent in human β-
myosin heavy chain also contains a 
cardiomyopathy site, Ala26 (Glu27 in both 
Drosophila EMB and IFI myosin) which could 
disrupt the signal transfer between the essential 
light chain and the purine binding loop. The 
essential light chain residue Arg154 (Gln106 
equivalent in Drosophila) can result in serious 
cardiomyopathy when mutated into His (25). 
Gln106 is close to ELC residues Glu104 and 
His107, which both interact with the NT helix 
(Figure 6C). Based on kinetic measurements, 
and molecular modeling, we propose that these 
mutations alter myosin function by disrupting 
the relay pathway between the nucleotide 
binding pocket and the essential light chain. A 
recent structure of beta-cardiac myosin (PDB: 
6FSA) shows a strong contact (salt-bridge) 
between exon 3 residue Asp85 and helix NT 
residue Arg29, in addition to contacts between 
exon 3 residue Tyr115 and purine binding loop 
residue Tyr134 (26), strongly supporting our 
hypothesis that the exon 3 area is part of the 
relay pathway towards the purine binding loop 
via helix NT.  
Disruption of the above-mentioned 
pathway does not only affect the cross-bridge 
kinetics but is also expected to alter the 
mechanical properties of myosin. The N-
terminal region (NTR) of myosin has been 
identified as an important element in tuning the 
mechanical properties of myosin-I (27). 
Exchange of the NTR from Myo-1b, a highly 
tension-sensitive motor, onto Myo-1c, which is 
less tension-sensitive, converts Myo-1c into a 
highly tension-sensitive motor, resulting in 
sensitivity to forces < 2 pN. Overlay of the 
crystal structures of Myo-1b (PDB: 4L79)(28) 
and the EMB crystal structure (PDB 5W1A) 
shows a remarkable similarity between the 
secondary structure elements of the N-terminal 
region of EMB and Myo-1b, except for the SH3 
domain of EMB (Figure 8). The NTR of Myo-
1b and a small helix immediately following the 
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NTR are located near helix A and helix B of 
EMB, whereas the longer helix C of EMB 
nearly overlaps with an equivalent longer helix 
of Myo-1b (see Figure 8A/B). Overlay of EMB 
with Myo-1c shows a similar picture (Figure 
8C) with the NTR and the first two helices of 
Myo-1c following the backbone topology of the 
exon 3 area secondary structure elements (helix 
A, B and C). The similarity between the N-
termini of EMB and the Myo-1b/Myo-1c 
structures suggests a similar functional role, 
implicating the exon 3 area as a mechano-
sensing element.  
Recent crystal structures of cardiac 
myosin with the myosin activator omecamtiv 
mecarbil (OM) bound also hint at the possibility 
that the exon 3 area is involved in fine-tuning 
the mechano-sensing properties of myosin (29, 
30). OM is a selective, small-molecule cardiac 
myosin activator that binds to the myosin head 
domain and can increase the power output of the 
cardiac muscle (31). OM is currently in clinical 
trials for the treatment of heart failure. Two 
cardiac myosin binding sites have been reported 
for OM (29, 30), one of which shows the OM-
binding site in a narrow cleft between the N-
terminal domain and lower 50K domain (29). 
Three out of six N-terminal domain residues 
that interact with OM are located in the exon 3 
area (A91, M92, L96), whereas the other three 
residues are just outside the exon 3 area on the 
loop between the first (S1β) and second β-strand 
(S2β) of the seven-stranded β-sheet (S118, G119 
and F121). Since OM can alter the power output 
of myosin, the involvement of exon 3 encoded 
residues in this process is another indication of 
this region’s potential in fine-tuning mechanical 
properties of myosin isoforms.  
 
In conclusion, we find that the alternatively 
expressed domain encoded by exon 3 in muscle 
myosin is critical for optimal myosin 
performance. Various steps in the cross-bridge 
cycle are affected by exchange of the exon 3 
regions, in particular ADP release and ATP-
binding. Based on the recently reported EMB 
crystal structure, combined with the homology 
modelling presented here, we propose that this 
exon 3 area is part of the communication 
pathway between the nucleotide binding pocket 
(purine-binding loop) and the essential light 
chain and plays an important role in modulating 





Generation of subfragment-1 (S1) from 
isolated full-length myosin   
Myosin was isolated from the indirect 
flight muscles of 140 wild-type (PwMhc2 
transgenics), 200 EMB, 140 IFI-3a or 300 
EMB-3b transgenic flies (those expressing the 
IFI, EMB, EMB-3b or IFI-3a myosin isoforms 
in the indirect flight muscles, respectively) as 
previously described (6). The production of S1 
by -chymotrypsin digestion was carried out 
using a method based on Silva et al. (32) with 
the following modifications: the final myosin 
pellet was dissolved in digestion buffer (120 
mM NaCl, 20 mM Na2PO4, pH 7.0, 1 mM 
EDTA, and 4 mM DTT). The myosin was 
incubated at 20 °C for 5 min to equilibrate, and 
then incubated with 0.2 mg/ml -chymotrypsin 
for 6 min. To quench the reaction, 
phenylmethylsulfonyl fluoride (PMSF) was 
added to a final concentration of 1.5 mM. The 
reaction was subsequently centrifuged at 60,000 
rpm (TLA 100.3 rotor) for 20 min in a Beckman 
ultracentrifuge to pellet the undigested myosin 
and myosin rods. The supernatant containing 
the S1 was removed and diluted to 1 ml with low 
salt buffer (30 mM KCl, 15 mM MgCl2, 20 mM 
MOPS, pH 7.0 and 4 mM DTT). To concentrate 
the S1, the samples were centrifuged at 15,000 
rpm in a Sorvall MC 12V microcentrifuge at 4 
°C using a Millipore Ultrafree 0.5 µm 
centrifugal filter with a 5,000 kDa cut-off. The 
final volume of the supernatant was 30-40 µl, 
containing an S1 concentration of roughly 1.5 – 
2 g/l. S1 concentration was determined from 
the absorbance at 280 nm (E1% = 0.73 cm–1) and 
the molecular mass of 115 kDa. 
 
Flash photolysis  
Because of the small amounts of 
protein available, flash photolysis was used to 
measure the kinetics of the mutant Drosophila 
myosin S1 (5, 33). The ATP-induced 
dissociation of the acto-S1 complex was 
followed by measuring changes in the light 
scattering signal. The dissociation of nucleotide 
from S1 alone was detected by changes in 
fluorescence using fluorescently labelled 
analogues. In brief, the 20 µl sample was held 
in a quartz cuvette and ATP was released by a 
single 5 ns flash at 353 nm from a neodymium-
yttrium-aluminum-garnet laser (Surelite I-10, 
70 mJ maximum power) along the vertical axis 
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of the cell at a rate of 90 s-1 to start the reaction. 
Both absorbance (to determine the ATP 
concentration) and light scattering (to monitor 
the acto-S1 complex) or fluorescence (to 
determine cmADP release) were measured from 
the cuvette simultaneously following the laser 
flash. White light > 389 nm was introduced to 
the sample from a 100-watt halogen lamp and 
the change in the amount of light scattered 90 
was monitored after each flash. The absorbance 
at 405 nm was measured with a monochromator 
to determine the amount of ATP liberated from 
caged ATP during each laser flash. Coumarin 
fluorescence changes were detected by 
monitoring the emission through a 455 nm cut-
off filter after excitation at 434 nm (75-watt 
xenon/mercury lamp).  
 All light scattering experiments were 
conducted in a low salt buffer (pH 7.0: 30 mM 
KCl, 5 mM MgCl2, 20 mM MOPS and 4 mM 
DTT) with 1 µM actin, 1-3 µM S1, 500 µM 
cATP, 10 mM DTT and either apyrase (2 
units/ml: ATP-induced dissociation of acto-S1) 
or ADP (various concentrations) and a glucose-
hexokinase system (0.03 units/ml hexokinase, 1 
mM glucose and 100 µM Ap5A: KAD 
determination). Each sample was subjected to 
multiple laser flashes. During KAD 
determination, ADP and cATP were added after 
each flash. The cmADP dissociation 
experiments were also performed in this low 
salt buffer and contained 4 µM S1, 10 µM 
cmATP (source of cmADP) and 100 µM cATP. 
For the determination of kcat, the acto-S1 sample, 
incubated without apyrase, was irradiated by a 
series of laser pulses of different intensities, 
which released a range of ATP concentrations. 
The time taken to hydrolyze all of the ATP (tcat) 
was estimated from the time at which the 
dissociation reaction was 50% complete (tdiss) to 
the time for 50% recovery of the light scattering 
(tass) (33).  
 
Analysis of the kinetic data  
Equation 1 was derived from the 
interaction of actin and S1 with ATP and ADP 
shown in Scheme 1 and was used to determine 
KAD. 
 
kobs = K1k+2([ATP]/(1 + [ADP]/KAD)) (1) 
 
where kobs is the observed rate constant for the 
ATP-induced dissociation of acto-S1; K1k+2 is 
the second-order rate constant for ATP binding 
to acto-S1; KAD is the equilibrium dissociation 
constant for the binding of ADP to acto-S1. The 
equation krel = kobs/ko was used to determine the 
relative rate constant (krel) shown in Figure 2D, 
where ko is the value when [ADP] = 0. Plotting 
tcat versus ATP concentration allows one to 
estimate the steady-state rate of ATP hydrolysis 
according to Equation 2: 
 
steady-state rate = [ATP]/tcat  (2) 
 
From which one can determine the kcat 
(Equation 3): 
 
kcat = steady-state rate/[S1] (3) 
 
Values reported for flash photolysis 
studies are mean ± S.D. based on a minimum of 
3 preparations, except kcat which is based on two 
preparations and therefore kcat is not included in 
the statistical analysis that was carried out by 
unpaired t tests and Welch's correction, with 
significant differences assumed at p<0.05. 
Significance was also assessed using one-way 
Welch’s ANOVA. 
 
Basal and actin-stimulated Mg-ATPase assays   
ATPase activities for myosin S1 were 
determined using 2 µg S1 samples and [γ-32P]-
ATP. Two technical samples were run for each 
biological replicate. Ca-ATPase activity was 
determined as previously described (6). Basal 
and actin-activated Mg-ATPase activities were 
determined using chicken skeletal muscle actin 
as previously described (7), with modifications 
(10). Notably, no salt (KCl) was added to the 
ATPase assay solution. G-actin was isolated 
from acetone powder of chicken skeletal muscle 
(34). After one cycle of polymerization-
depolymerization, soluble G-actin obtained 
after dialysis against 2 mM Tris-HCl, pH 8.0, 
0.2 mM ATP, 2 mM CaCl2 and 1 mM DTT was 
quantified spectrophotometrically using an 
extinction coefficient of 0.62 cm-1 (A310nm-
A290nm) for 1 mg ml-1. F-actin was prepared by 
adding 1 volume of 10X polymerization buffer 
(50 mM Tris-HCl, pH 8.0, 0.5 M KCl, 20 mM 
MgCl2 and 10 mM ATP) to 9 volumes of G-
actin. The working F-actin solution had a 
concentration of ~300 μM. For the Mg-ATPase 
activity assays, myosin was added to Mg-
ATPase solution (10 mM imidazole pH 6.0, 0.1 
mM CaCl2, 1 mM MgCl2, 1 mM [γ-32P]-ATP) 
with increasing concentrations of F-actin (0 to 
15 M). The reaction was quenched using 1.8 N 
HClO4 after 25 min at room temperature prior 
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to extraction and scintillation counting. Vmax and 
Km values were obtained by fitting data, after 
subtraction of basal Mg-ATPase values, with 
the Michaelis-Menten equation using Prism 
(Graph Pad) software. ATPase values are 
presented as mean ± SD. Statistical significance 
was assessed using unpaired t tests and Welch's 
correction, with significant differences assumed 
at p<0.05.  
 
Homology modelling  
Three-dimensional homology models 
were generated for the Drosophila IFI myosin 
motor domain and exon 3 chimeras using the 
SWISS-MODEL automatic comparative 
protein modeling server (35–37). The 
embryonic myosin crystal structure (PDB 
5W1A) was used as a template to build a 
homology model of the IFI isoform, after 
pairwise alignment of the primary sequences of 
the Drosophila IFI and EMB S1 domains (96% 
conserved). To represent various states from the 
cross-bridge cycle, scallop myosin structures 
were also used as templates: PDB 1KK8 (actin-
detached state), 1QVI (pre-power stroke state) 
and 1S5G (near-rigor ADP-bound state) using 
the CLUSTALW alignment protocol. The 
alignments were submitted to the alignment 
interface of SWISS-MODEL. The chosen 
templates allowed us to generate 3D homology 
models of the IFI and EMB myosin heads and 
of the chimeras obtained after swapping the 
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Abbreviations and nomenclature: 
MHC  Myosin heavy chain 
EMB  Embryonic muscle myosin isoform in Drosophila 
IFI  Adult indirect flight muscle isoform of myosin 
IFM  Indirect flight muscle 
ELC  Essential light chain  
myosinS1 Myosin proteolytic subfragment-1 
cmADP coumarin-ADP 
cATP  caged ATP 
Tpm  tropomyosin 
NTR  N-terminal region 
OM  omecamtiv mecarbil  
PMSF  phenylmethylsulfonyl fluoride   







Figure 1: (A) Structure of the embryonic myosin isoform (EMB) in the rigor-like conformation, with 
the location of the four variable regions in the myosin head indicated: exon 3 region (green), exon 7 
region (purple), exon 9 region (dark red) and exon 11 region (light brown). The essential light chain 
(ELC) is shown in dark-grey (the coordinates of the EMB crystal structure (PDB: 5W1A) were used to 
generate this image). (B) Alternative sequences encoded by the exon 3a and 3b regions, with non-
conservative differences denoted by asterisks: 3a is found in the slow EMB isoform and 3b is present in 
the fast IFI isoform. 
 
  





Figure 2: ATP-induced dissociation (K1k+2) and ADP affinity (KAD) of the two myosin S1 exon 3 
chimeras. (A) Example of light scattering traces for acto-S1 dissociation with EMB-3b S1 (B) The 
second order rate constant (K1k+2) for the ATP-induced dissociation of S1 from actin is determined from 
a linear fit to the plot of the kobs vs. [ATP] (see Experimental Procedures). The linear fits yielded values 
of 0.71 ± 0.12 μM-1 s-1 for EMB-3b (●) as compared to 0.91 ± 0.13 μM-1 s-1 for EMB (○). For IFI-3a the 
linear fits yielded mean values of 0.66 ± 0.08 μM-1 s-1 (■) as compared to 0.75 ± 0.08 μM-1 s-1 for IFI S1 
(□). (C) Light scattering traces for acto-S1 dissociation with EMB-3b S1 at various ADP concentrations. 
(D) Comparison of the affinity of ADP for acto-S1 (KAD) for EMB and EMB-3b, with the relative kobs 
(krel) values shown. Hyperbolic fits resulted in KAD values of 587 ± 48 μM for EMB (open circles) and 
496 ± 79 μM for EMB-3b S1 (closed circles). 
 
  









Figure 3: Rate of ADP release (k-D) from Drosophila S1 isoforms. The rate constant for cm.ADP 
dissociation (k-D) from S1 in the absence of actin was determined using flash photolysis. After release 
of ATP (15 µM) from caged-ATP (100 µM), a fluorescent ADP analogue (eda-deac ADP) bound to S1 
was displaced by ATP. The change in fluorescence upon release of eda-deac ADP from S1 was used to 
determine k-D. Exchange of either the exon 3a or 3b domain resulted in a complete reversal of the ADP 
release rate (see also Table 1). The dissociation rate for EMB-3b (k-D: 7.0 s-1) is not significantly different 
to IFI (k-D: 7.5 s-1) whereas that of IFI-3a (k-D: 2.1 s-1) is similar to EMB (k-D 1.8 s-1).  
 
  





Figure 4: Steady-state ATPase activity of IFI, EMB and exon 3 chimeric S1 isoforms. (A) Basal 
Ca-ATPase activity, (B) basal Mg-ATPase, (C) actin-activated Mg-ATPase activity (Vmax) and (D) the 
turnover number (kcat) for acto-S1 were determined as described in Experimental Procedures. Notations 
above histograms indicate the level of statistically significant differences (*, p < 0.05; **, p < 0.01; ***, 
p < 0.001; ****, p < 0.0001, ns, not statistically significant). Significant differences were assumed for 
















Figure 5: Location and structure of exon 3 domain (green) within the myosin heavy chain N-
terminus. (A) Secondary structure elements encoded by exon 3 (residues 69-116) include β4 (69-73), 
β5 (77-79), helix A (HA,83-85), helix B (HB, 91-93), helix C (HC, 98 -111) and the first β-strand of 
the seven-stranded β-sheet S1β (starts at 115, indicated with an arrow). The full SH3 element is also 
depicted (β1Lys36-Glu43, β2: Glu45-Lys56, β3: Ile59-Gln65). (B) Conserved interactions within exon 
3 regions involve residues Asp90, Asn105, Arg109 and Tyr116. Asn105 forms hydrogen bonds with 
backbone oxygens of three residues close to Asp90 (Lys87, Ile/Ala88 and Met91) whereas Arg109 forms 
















Figure 6: The exon 3 area is part of the communication pathway between the essential light chain 
and the purine binding loop. (A) Overview of elements in the communication pathway between the 
ELC (blue) and purine binding loop (127-135, orange), shown for rigor-like EMB myosin S1 (PDB: 
5W1A). In addition to the exon 3 area (69-116, green), the small N-terminal helix (21-30, red) is also 
involved in signal transfer from the ELC towards the nucleotide binding pocket. (B) Detailed view of 
purine-binding loop interactions with the exon 3 area and the P-loop (PDB: 5W1A). Figure 6B is reused 
and extended in the supplementary section to demonstrate that interaction of the exon 3 region with the 
purine binding loop depends on conformational state of the myosin head (Figures S2/S3). (C) Close up 

















Figure 7: Exon 3 interaction with helix NT is distinct between IFI and EMB and depends on 
conformational state. Comparison of helix NT interaction with exon 3 residues and the ELC throughout 
the crossbridge cycle for IFI and EMB myosin isoforms, with exon 3 area (residues 69-116) in green, 
the NT-helix (residues 21-30) in red and the essential light chain (ELC) in blue. (A) Near rigor state: 
EMB crystal structure (PDB 5W1A) and corresponding IFI homology model show similar interaction 
of helix NT with exon 3 region and ELC (B) Pre-power stroke state: interaction of helix NT (Arg24) with 
the exon 3 area is present for IFI (Asn112) whereas for EMB (Ala112) this interaction is absent (PDB 
template 1QVI). (C) Post-power stroke state: IFI maintains contacts between the sidechains of variable 
exon 3 residue Asn112 and helix NT residue Arg24. Additional contacts are found for exon 3 residues 
Pro83 and Lys84 (backbone oxygen) with helix NT residue Arg25(sidechain). No exon 3 - helix NT 













Figure 8: Overlay of N-terminal regions of EMB and Myo-1b or Myo-1c.  
(A-B) EMB (grey) with the exon 3 area (green) and the N-terminal helix (NT) shown in red, Myo-1b 
(purple) and Myo-1c (yellow). Note the similar orientation of exon 3 secondary structure elements (helix 
B and C) of EMB with respect to the N-terminal region (NTR) of Myo-1b and/or Myo-1c in both near-
rigor and pre-power stroke state. (A) Overlay of crystal structures of Myo-1b (4L79) with EMB (rigor-
like, 5W1A). (B) Overlay of Myo-1b (6C1D) and Myo-1c (4BYF) with EMB homology model (pre-
power stroke, 1QVI template). (C) Sequence alignment of N-terminal regions of EMB and Myo-1b 
showing conserved secondary structure elements (HB and HC) for the exon-3 encoded region (EMB) 
and the NTR (Myo-1b). 
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Table 1: Kinetic parameters measured for myosin S1 isoforms and the exon 3 chimeras using flash 
photolysis. Values are mean ± S.D. based on a minimum of 3 preparations except kcat (n=2). K1k+2 is 
the second order rate constant for ATP-induced dissociation of acto-S1. KD and KAD are dissociation 
equilibrium constants determined by division of the dissociation rate constant by the association rate 
constant (e.g. KD = k-D / k+D). k-D and k-AD are the ADP dissociation rate constants in the absence and 
presence of actin, respectively. KAD / KD is the thermodynamic coupling constant describing the 















































































† Data are from (5) except kcat  
a Statistically different compared to IFI, p<0.04 by t test, but did not reach statistical 
significance using Welch’s one-way ANOVA. 
b Statistically different compared to EMB, p<0.007. 
c Statistically different compared to EMB, p<0.04 by t test, but did not reach statistical 
significance using Welch’s one-way ANOVA.  
d Data are estimated from KAD assuming an association rate constant of 10
7 M-1 s-1. 
e Data are estimated from k-D assuming an association rate constant of 106 M-1 s-1. 
f Statistically different compared to IFI, p<0.0001. 
g Statistically different compared to EMB, p<0.0001. 
h Actin is not at saturating conditions  
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Table 2: Steady-state kinetic parameters measured for wild-type IFI, IFI-3a, EMB and EMB-3b 
Drosophila myosin S1. Values are mean ± S.D. based on a minimum of four preparations (except for 
EMB Ca-ATPase, which is 3). 
 









IFI 9.79±1.39 0.092±0.035 1.25±0.29 3.26±2.36  
IFI-3a 4.92±1.05a  0.066±0.047   1.07±0.26 2.38±0.91 
EMB-3b 5.16±2.01b  0.053±0.039  0.83±0.37 2.95±2.95  
EMB 1.83±0.08 
 
0.016±0.002ǂ 0.67±0.06ǂ  2.54±0.46ǂ 
ǂ Data from (10) 
 
a Statistically different compared to IFI, p < 0.0001  
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IFI-3a 6.5 6.2 409 0.66 1.32 4090 1300 1240  2640  1320 
IFI 6.4 5.7 409b 0.75b 1.50 4090 1280 1140  3000  1500 
EMB-3b 3.8 5.2 496 0.71 1.42 4960 760 1040  2840  1420 
EMB 0.7 4.0 587b 0.91b 1.82 5870 140 800  3640  1820 
a From (7) Tpm is tropomyosin, * indicates parameters determined in the presence of tropomyosin 
b From (5) 
c Value of K1k+2 corrected for inhibition of the ATP reaction by cATP (correction factor 2, (18)). 
d Assumes k+AD = 107 M-1s-1 and k-AD = KAD x k+AD. 
e Assumes kdiss = K1k+2 x [ATP] and [ATP] is 2 mM (ATP concentration used in motility assays). 
f Assumes kdiss = K1k+2 x [ATP] and [ATP] is 1 mM 
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Scheme 1: The interaction of S1 with actin, ATP and ADP. M, A, T and D symbolize myosin S1, 
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